FDA approves new orphan drug for chronic myelogenous leukemia

by FDA on September 4, 2012

in FDA Alerts

Today the U.S. Food and Drug Administration approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults.

This is a summary of a Press Release issued by the Food and Drug Administration (FDA). The link below will take you to the original press release containing complete information, including instructions about what to do if you are affected.

View Full Details Of Original FDA Press Release Here.

Leave a Comment

Previous post:

Next post: